Gyre Therapeutics (GYRE) Cash from Operations (QoQ) (2010 - 2026)
Gyre Therapeutics (GYRE) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
157.14% |
| Dec 31, 2025 |
-221.74% |
| Sep 30, 2025 |
116.06% |
| Jun 30, 2025 |
1,750.39% |
| Mar 31, 2025 |
95.32% |
| Dec 31, 2024 |
-259.79% |
| Sep 30, 2024 |
131.42% |
| Jun 30, 2024 |
-290.46% |
| Mar 31, 2024 |
-14.17% |
| Dec 31, 2023 |
-55.68% |
| Sep 30, 2023 |
67.26% |
| Jun 30, 2023 |
-56.48% |
| Mar 31, 2023 |
-75.37% |
| Dec 31, 2022 |
681.26% |
| Sep 30, 2022 |
40.81% |
| Jun 30, 2022 |
-2.02% |
| Mar 31, 2022 |
31.83% |
| Dec 31, 2021 |
18.17% |
| Sep 30, 2021 |
-7.34% |
| Jun 30, 2021 |
17.38% |
